Teladoc Health Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Teladoc Health Corp from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
04/11/2025 | Buy Now | — | B of A Securities | Allen Lutz61% | $9.5 → $8 | Maintains | Neutral | Get Alert |
03/03/2025 | Buy Now | — | Goldman Sachs | David Roman35% | $16 → $13 | Maintains | Buy | Get Alert |
02/27/2025 | Buy Now | — | Needham | Ryan MacDonald57% | — | Reiterates | Hold → Hold | Get Alert |
02/27/2025 | Buy Now | — | Piper Sandler | Jessica Tassan40% | $13 → $12 | Maintains | Overweight | Get Alert |
02/18/2025 | Buy Now | — | Goldman Sachs | David Roman35% | $14 → $16 | Maintains | Buy | Get Alert |
02/12/2025 | Buy Now | — | B of A Securities | Allen Lutz61% | $11.5 → $13.5 | Maintains | Neutral | Get Alert |
02/06/2025 | Buy Now | — | B of A Securities | Allen Lutz61% | $10.5 → $11.5 | Maintains | Neutral | Get Alert |
01/24/2025 | Buy Now | — | RBC Capital | Sean Dodge48% | $11 → $12 | Maintains | Outperform | Get Alert |
01/24/2025 | Buy Now | — | Oppenheimer | Michael Wiederhorn62% | $14 → $12 | Maintains | Outperform | Get Alert |
12/04/2024 | Buy Now | — | Piper Sandler | Jessica Tassan40% | $11 → $13 | Reiterates | Overweight → Overweight | Get Alert |
11/15/2024 | Buy Now | — | Goldman Sachs | David Roman35% | → $14 | Initiates | → Buy | Get Alert |
11/01/2024 | Buy Now | — | Deutsche Bank | George Hill63% | $10 → $12 | Maintains | Hold | Get Alert |
10/31/2024 | Buy Now | — | Barclays | Steve Valiquette54% | $10 → $12 | Maintains | Overweight | Get Alert |
10/31/2024 | Buy Now | — | TD Cowen | Charles Rhyee37% | $9 → $8 | Maintains | Hold | Get Alert |
10/09/2024 | Buy Now | — | RBC Capital | Sean Dodge48% | $9 → $10 | Maintains | Outperform | Get Alert |
10/08/2024 | Buy Now | — | Evercore ISI Group | Elizabeth Anderson44% | $8 → $9 | Maintains | In-Line | Get Alert |
09/17/2024 | Buy Now | — | Jefferies | Glen Santangelo50% | $8 → $10 | Maintains | Hold | Get Alert |
08/26/2024 | Buy Now | — | JP Morgan | Lisa Gill60% | $16 → $9 | Maintains | Neutral | Get Alert |
08/20/2024 | Buy Now | — | Cantor Fitzgerald | Sarah James52% | $10 → $10 | Reiterates | Overweight → Overweight | Get Alert |
08/06/2024 | Buy Now | — | Piper Sandler | Jessica Tassan40% | $25 → $10 | Maintains | Overweight | Get Alert |
08/02/2024 | Buy Now | — | Deutsche Bank | George Hill63% | $15 → $10 | Maintains | Hold | Get Alert |
08/02/2024 | Buy Now | — | Truist Securities | Jailendra Singh39% | $15 → $10 | Maintains | Hold | Get Alert |
08/01/2024 | Buy Now | — | Needham | Ryan MacDonald57% | — | Reiterates | → Hold | Get Alert |
08/01/2024 | Buy Now | — | TD Cowen | Charles Rhyee37% | $15 → $9 | Maintains | Hold | Get Alert |
08/01/2024 | Buy Now | — | RBC Capital | Sean Dodge48% | $18 → $9 | Maintains | Outperform | Get Alert |
08/01/2024 | Buy Now | — | Barclays | Steve Valiquette54% | $20 → $10 | Maintains | Overweight | Get Alert |
08/01/2024 | Buy Now | — | Stifel | David Grossman63% | $16 → $9 | Maintains | Hold | Get Alert |
08/01/2024 | Buy Now | — | DA Davidson | Gil Luria50% | $12 → $8 | Maintains | Neutral | Get Alert |
08/01/2024 | Buy Now | — | Canaccord Genuity | Richard Close46% | $25 → $17 | Maintains | Buy | Get Alert |
08/01/2024 | Buy Now | — | Oppenheimer | Michael Wiederhorn62% | $21 → $17 | Maintains | Outperform | Get Alert |
07/09/2024 | Buy Now | — | Evercore ISI Group | Elizabeth Anderson44% | $14 → $10 | Maintains | In-Line | Get Alert |
05/21/2024 | Buy Now | — | JP Morgan | Lisa Gill60% | $19 → $16 | Maintains | Neutral | Get Alert |
05/20/2024 | Buy Now | — | Jefferies | Glen Santangelo50% | $16 → $14 | Maintains | Hold | Get Alert |
05/14/2024 | Buy Now | — | B of A Securities | Allen Lutz61% | $16.5 → $13.5 | Maintains | Neutral | Get Alert |
04/29/2024 | Buy Now | — | Wells Fargo | Stephen Baxter58% | $17 → $15 | Maintains | Equal-Weight | Get Alert |
04/26/2024 | Buy Now | — | Oppenheimer | Michael Wiederhorn62% | $26 → $21 | Maintains | Outperform | Get Alert |
04/26/2024 | Buy Now | — | TD Cowen | Charles Rhyee37% | $16 → $15 | Maintains | Hold | Get Alert |
04/26/2024 | Buy Now | — | Evercore ISI Group | — | $15 → $14 | Maintains | In-Line | Get Alert |
04/26/2024 | Buy Now | — | RBC Capital | Sean Dodge48% | $25 → $18 | Maintains | Outperform | Get Alert |
04/26/2024 | Buy Now | — | Stifel | David Grossman63% | $21 → $16 | Maintains | Hold | Get Alert |
04/26/2024 | Buy Now | — | Barclays | Steve Valiquette54% | $25 → $20 | Maintains | Overweight | Get Alert |
04/26/2024 | Buy Now | — | Canaccord Genuity | Richard Close46% | $28 → $25 | Maintains | Buy | Get Alert |
04/26/2024 | Buy Now | — | Needham | Ryan MacDonald57% | — | Reiterates | → Hold | Get Alert |
04/05/2024 | Buy Now | — | Needham | Ryan MacDonald57% | — | Reiterates | → Hold | Get Alert |
03/06/2024 | Buy Now | — | Truist Securities | Jailendra Singh39% | $23 → $17 | Maintains | Hold | Get Alert |
02/29/2024 | Buy Now | — | Cantor Fitzgerald | Sarah James52% | → $22 | Initiates | → Overweight | Get Alert |
02/26/2024 | Buy Now | — | Leerink Partners | Michael Cherny79% | → $17 | Initiates | → Market Perform | Get Alert |
02/21/2024 | Buy Now | — | DA Davidson | Gil Luria50% | $22 → $18 | Maintains | Neutral | Get Alert |
02/21/2024 | Buy Now | — | Citigroup | Daniel Grosslight44% | $21 → $19 | Maintains | Neutral | Get Alert |
02/21/2024 | Buy Now | — | RBC Capital | Sean Dodge48% | $30 → $25 | Maintains | Outperform | Get Alert |
02/21/2024 | Buy Now | — | Barclays | Steve Valiquette54% | $26 → $25 | Maintains | Overweight | Get Alert |
02/21/2024 | Buy Now | — | Piper Sandler | Jessica Tassan40% | $30 → $25 | Maintains | Overweight | Get Alert |
02/21/2024 | Buy Now | — | Canaccord Genuity | Richard Close46% | $34 → $28 | Maintains | Buy | Get Alert |
11/17/2023 | Buy Now | — | JP Morgan | Lisa Gill60% | $33 → $19 | Maintains | Neutral | Get Alert |
10/25/2023 | Buy Now | — | RBC Capital | Sean Dodge48% | $35 → $30 | Maintains | Outperform | Get Alert |
10/25/2023 | Buy Now | — | Oppenheimer | Michael Wiederhorn62% | $35 → $26 | Maintains | Outperform | Get Alert |
10/23/2023 | Buy Now | — | Citigroup | Daniel Grosslight44% | $29 → $21 | Maintains | Neutral | Get Alert |
10/20/2023 | Buy Now | — | Citigroup | Daniel Grosslight44% | $29 → $21 | Maintains | Neutral | Get Alert |
09/25/2023 | Buy Now | — | Truist Securities | Jailendra Singh39% | → $28 | Reiterates | Hold → Hold | Get Alert |
07/26/2023 | Buy Now | — | Stephens & Co. | Jeff Garro40% | → $28 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
07/26/2023 | Buy Now | — | RBC Capital | Sean Dodge48% | → $35 | Reiterates | Outperform → Outperform | Get Alert |
07/26/2023 | Buy Now | — | Citigroup | Daniel Grosslight44% | $31 → $29 | Maintains | Neutral | Get Alert |
07/26/2023 | Buy Now | — | Credit Suisse | Jonathan Yong65% | → $27 | Reiterates | Neutral → Neutral | Get Alert |
04/28/2023 | Buy Now | — | Deutsche Bank | George Hill63% | $27 → $29 | Maintains | Hold | Get Alert |
04/27/2023 | Buy Now | — | Citigroup | Daniel Grosslight44% | $30 → $31 | Maintains | Neutral | Get Alert |
04/27/2023 | Buy Now | — | RBC Capital | Sean Dodge48% | → $35 | Reiterates | → Outperform | Get Alert |
04/27/2023 | Buy Now | — | Credit Suisse | Jonathan Yong65% | → $27 | Reiterates | → Neutral | Get Alert |
04/27/2023 | Buy Now | — | Barclays | Steve Valiquette54% | $28 → $29 | Maintains | Equal-Weight | Get Alert |
04/12/2023 | Buy Now | — | Stephens & Co. | Jeff Garro40% | → $25 | Initiates | → Equal-Weight | Get Alert |
03/10/2023 | Buy Now | — | Credit Suisse | Jonathan Yong65% | $30 → $27 | Maintains | Neutral | Get Alert |
03/06/2023 | Buy Now | — | Canaccord Genuity | Richard Close46% | $40 → $36 | Maintains | Buy | Get Alert |
03/06/2023 | Buy Now | — | Wells Fargo | Stan Berenshteyn40% | $28 → $23 | Maintains | Equal-Weight | Get Alert |
02/28/2023 | Buy Now | — | Citigroup | Daniel Grosslight44% | $33 → $30 | Maintains | Neutral | Get Alert |
02/27/2023 | Buy Now | — | Deutsche Bank | George Hill63% | $31 → $27 | Maintains | Hold | Get Alert |
02/27/2023 | Buy Now | — | JP Morgan | Lisa Gill60% | $35 → $33 | Maintains | Neutral | Get Alert |
02/23/2023 | Buy Now | — | Oppenheimer | Michael Wiederhorn62% | $37 → $35 | Maintains | Outperform | Get Alert |
02/23/2023 | Buy Now | — | RBC Capital | Sean Dodge48% | → $35 | Reiterates | → Outperform | Get Alert |
02/23/2023 | Buy Now | — | SVB Leerink | Stephanie Davis40% | → $34 | Upgrade | Market Perform → Outperform | Get Alert |
01/19/2023 | Buy Now | — | Oppenheimer | Colin Rusch53% | $45 → $37 | Maintains | Outperform | Get Alert |
01/18/2023 | Buy Now | — | Barclays | Marc Solecitto60% | $32 → $28 | Maintains | Equal-Weight | Get Alert |
12/13/2022 | Buy Now | — | Citigroup | Daniel Grosslight44% | $36 → $33 | Maintains | Neutral | Get Alert |
10/31/2022 | Buy Now | — | Credit Suisse | Jonathan Yong65% | $35 → $30 | Maintains | Neutral | Get Alert |
10/27/2022 | Buy Now | — | Citigroup | Daniel Grosslight44% | $38 → $36 | Maintains | Neutral | Get Alert |
10/27/2022 | Buy Now | — | Barclays | Steve Valiquette54% | $33 → $32 | Maintains | Equal-Weight | Get Alert |
10/25/2022 | Buy Now | — | DA Davidson | Robert Simmons52% | $45 → $40 | Maintains | Buy | Get Alert |
10/24/2022 | Buy Now | — | Guggenheim | Sandy Draper73% | — | Upgrade | Sell → Neutral | Get Alert |
10/21/2022 | Buy Now | — | Truist Securities | Jailendra Singh39% | $35 → $29 | Maintains | Hold | Get Alert |
10/11/2022 | Buy Now | — | Barclays | Steve Valiquette54% | $40 → $33 | Maintains | Equal-Weight | Get Alert |
09/28/2022 | Buy Now | — | RBC Capital | Sean Dodge48% | $53 → $35 | Maintains | Outperform | Get Alert |
09/27/2022 | Buy Now | — | Deutsche Bank | George Hill63% | $34 → $31 | Maintains | Hold | Get Alert |
09/16/2022 | Buy Now | — | Keybanc | Scott Schoenhaus45% | — | Initiates | → Sector Weight | Get Alert |
09/07/2022 | Buy Now | — | Truist Securities | Jailendra Singh39% | → $35 | Initiates | → Hold | Get Alert |
08/17/2022 | Buy Now | — | Guggenheim | Sandy Draper73% | → $25 | Downgrade | Neutral → Sell | Get Alert |
08/12/2022 | Buy Now | — | DA Davidson | Robert Simmons52% | → $45 | Initiates | → Buy | Get Alert |
08/02/2022 | Buy Now | — | Berenberg | Ravi Misra34% | $42 → $35 | Downgrade | Buy → Hold | Get Alert |
08/02/2022 | Buy Now | — | Cowen & Co. | Charles Rhyee37% | $58 → $34 | Downgrade | Outperform → Market Perform | Get Alert |
07/28/2022 | Buy Now | — | Goldman Sachs | Cindy Motz29% | $55 → $36 | Downgrade | Buy → Neutral | Get Alert |
07/28/2022 | Buy Now | — | Barclays | Steve Valiquette54% | $42 → $40 | Maintains | Equal-Weight | Get Alert |
07/28/2022 | Buy Now | — | Needham | Ryan MacDonald57% | — | Downgrade | Buy → Hold | Get Alert |
07/28/2022 | Buy Now | — | Piper Sandler | Jessica Tassan40% | $42 → $40 | Maintains | Overweight | Get Alert |
The latest price target for Teladoc Health (NYSE:TDOC) was reported by B of A Securities on April 11, 2025. The analyst firm set a price target for $8.00 expecting TDOC to rise to within 12 months (a possible 17.13% upside). 43 analyst firms have reported ratings in the last year.
The latest analyst rating for Teladoc Health (NYSE:TDOC) was provided by B of A Securities, and Teladoc Health maintained their neutral rating.
The last upgrade for Teladoc Health Inc happened on February 23, 2023 when SVB Leerink raised their price target to $34. SVB Leerink previously had a market perform for Teladoc Health Inc.
The last downgrade for Teladoc Health Inc happened on August 17, 2022 when Guggenheim changed their price target from N/A to $25 for Teladoc Health Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Teladoc Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Teladoc Health was filed on April 11, 2025 so you should expect the next rating to be made available sometime around April 11, 2026.
While ratings are subjective and will change, the latest Teladoc Health (TDOC) rating was a maintained with a price target of $9.50 to $8.00. The current price Teladoc Health (TDOC) is trading at is $6.83, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.